vs
Side-by-side financial comparison of MSCI Inc. (MSCI) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $822.5M, roughly 1.8× MSCI Inc.). MSCI Inc. runs the higher net margin — 34.6% vs -13.6%, a 48.2% gap on every dollar of revenue. On growth, MSCI Inc. posted the faster year-over-year revenue change (10.6% vs -5.3%). MSCI Inc. produced more free cash flow last quarter ($488.7M vs $96.0M). Over the past eight quarters, MSCI Inc.'s revenue compounded faster (10.0% CAGR vs -3.6%).
MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
MSCI vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $822.5M | $1.5B |
| Net Profit | $284.7M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 56.4% | -9.8% |
| Net Margin | 34.6% | -13.6% |
| Revenue YoY | 10.6% | -5.3% |
| Net Profit YoY | -6.8% | -288.1% |
| EPS (diluted) | $3.81 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $822.5M | $1.5B | ||
| Q3 25 | $793.4M | $1.6B | ||
| Q2 25 | $772.7M | $1.6B | ||
| Q1 25 | $745.8M | $1.5B | ||
| Q4 24 | $743.5M | $1.6B | ||
| Q3 24 | $724.7M | $1.6B | ||
| Q2 24 | $707.9M | $1.6B | ||
| Q1 24 | $680.0M | $1.6B |
| Q4 25 | $284.7M | $-205.0M | ||
| Q3 25 | $325.4M | $160.0M | ||
| Q2 25 | $303.6M | $145.0M | ||
| Q1 25 | $288.6M | $87.0M | ||
| Q4 24 | $305.5M | $109.0M | ||
| Q3 24 | $280.9M | $359.0M | ||
| Q2 24 | $266.8M | $195.0M | ||
| Q1 24 | $256.0M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 56.4% | -9.8% | ||
| Q3 25 | 56.4% | 15.2% | ||
| Q2 25 | 55.0% | 14.4% | ||
| Q1 25 | 50.6% | 6.7% | ||
| Q4 24 | 54.5% | 8.1% | ||
| Q3 24 | 55.4% | 13.1% | ||
| Q2 24 | 54.0% | 14.6% | ||
| Q1 24 | 49.9% | 14.5% |
| Q4 25 | 34.6% | -13.6% | ||
| Q3 25 | 41.0% | 10.0% | ||
| Q2 25 | 39.3% | 9.1% | ||
| Q1 25 | 38.7% | 5.8% | ||
| Q4 24 | 41.1% | 6.8% | ||
| Q3 24 | 38.8% | 22.7% | ||
| Q2 24 | 37.7% | 12.1% | ||
| Q1 24 | 37.6% | 12.4% |
| Q4 25 | $3.81 | $-0.78 | ||
| Q3 25 | $4.25 | $0.61 | ||
| Q2 25 | $3.92 | $0.56 | ||
| Q1 25 | $3.71 | $0.33 | ||
| Q4 24 | $3.89 | $0.42 | ||
| Q3 24 | $3.57 | $1.38 | ||
| Q2 24 | $3.37 | $0.75 | ||
| Q1 24 | $3.22 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $515.3M | $574.0M |
| Total DebtLower is stronger | $6.2B | $8.6B |
| Stockholders' EquityBook value | $-2.7B | $752.0M |
| Total Assets | $5.7B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $515.3M | $574.0M | ||
| Q3 25 | $400.1M | $672.0M | ||
| Q2 25 | $347.3M | $599.0M | ||
| Q1 25 | $360.7M | $547.0M | ||
| Q4 24 | $409.4M | $675.0M | ||
| Q3 24 | $501.0M | $763.0M | ||
| Q2 24 | $451.4M | $704.0M | ||
| Q1 24 | $519.3M | $575.0M |
| Q4 25 | $6.2B | $8.6B | ||
| Q3 25 | $5.5B | $8.8B | ||
| Q2 25 | $4.5B | $8.9B | ||
| Q1 25 | $4.5B | $9.0B | ||
| Q4 24 | $4.5B | $8.9B | ||
| Q3 24 | $4.5B | $8.7B | ||
| Q2 24 | $4.5B | $8.7B | ||
| Q1 24 | $4.5B | $8.7B |
| Q4 25 | $-2.7B | $752.0M | ||
| Q3 25 | $-1.9B | $906.0M | ||
| Q2 25 | $-886.2M | $733.0M | ||
| Q1 25 | $-958.6M | $542.0M | ||
| Q4 24 | $-940.0M | $472.0M | ||
| Q3 24 | $-751.0M | $493.0M | ||
| Q2 24 | $-734.5M | $144.0M | ||
| Q1 24 | $-650.5M | $48.0M |
| Q4 25 | $5.7B | $12.9B | ||
| Q3 25 | $5.4B | $13.6B | ||
| Q2 25 | $5.4B | $13.5B | ||
| Q1 25 | $5.3B | $13.2B | ||
| Q4 24 | $5.4B | $13.1B | ||
| Q3 24 | $5.4B | $12.8B | ||
| Q2 24 | $5.5B | $12.2B | ||
| Q1 24 | $5.5B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $501.1M | $141.0M |
| Free Cash FlowOCF − Capex | $488.7M | $96.0M |
| FCF MarginFCF / Revenue | 59.4% | 6.4% |
| Capex IntensityCapex / Revenue | 1.5% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $501.1M | $141.0M | ||
| Q3 25 | $449.4M | $264.0M | ||
| Q2 25 | $336.1M | $220.0M | ||
| Q1 25 | $301.7M | $75.0M | ||
| Q4 24 | $430.6M | $390.0M | ||
| Q3 24 | $421.6M | $141.0M | ||
| Q2 24 | $349.2M | $332.0M | ||
| Q1 24 | $300.1M | $76.0M |
| Q4 25 | $488.7M | $96.0M | ||
| Q3 25 | $445.5M | $218.0M | ||
| Q2 25 | $324.7M | $181.0M | ||
| Q1 25 | $290.2M | $43.0M | ||
| Q4 24 | $416.4M | $335.0M | ||
| Q3 24 | $415.0M | $99.0M | ||
| Q2 24 | $340.6M | $300.0M | ||
| Q1 24 | $295.9M | $30.0M |
| Q4 25 | 59.4% | 6.4% | ||
| Q3 25 | 56.2% | 13.6% | ||
| Q2 25 | 42.0% | 11.4% | ||
| Q1 25 | 38.9% | 2.8% | ||
| Q4 24 | 56.0% | 21.0% | ||
| Q3 24 | 57.3% | 6.3% | ||
| Q2 24 | 48.1% | 18.7% | ||
| Q1 24 | 43.5% | 1.8% |
| Q4 25 | 1.5% | 3.0% | ||
| Q3 25 | 0.5% | 2.9% | ||
| Q2 25 | 1.5% | 2.4% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 1.9% | 3.5% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 1.2% | 2.0% | ||
| Q1 24 | 0.6% | 2.8% |
| Q4 25 | 1.76× | — | ||
| Q3 25 | 1.38× | 1.65× | ||
| Q2 25 | 1.11× | 1.52× | ||
| Q1 25 | 1.05× | 0.86× | ||
| Q4 24 | 1.41× | 3.58× | ||
| Q3 24 | 1.50× | 0.39× | ||
| Q2 24 | 1.31× | 1.70× | ||
| Q1 24 | 1.17× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSCI
| Recurring Subscriptions | $246.4M | 30% |
| Asset Based Fees | $211.7M | 26% |
| Analytics Segment | $182.3M | 22% |
| Sustainability And Climate Segment | $90.3M | 11% |
| Other | $70.9M | 9% |
| Non Recurring | $21.1M | 3% |
OGN
Segment breakdown not available.
